In another roller coaster year for medtech, these are the companies that saw their stock rise and fall the most drastically. The MassDevice MedTech 100 Index, which includes stocks of the world’s largest medical device companies, reflects the performance of many in the medtech space. In a tough year for a lot of businesses, the Index […]
Johnson & Johnson
The top 10 cardiac device stories of 2022
From pulsed-field ablation to noninvasive monitoring, this was an exciting year for cardiac device tech. Here are the top 10 cardiac device stories from MassDevice and its sister sites: 10. Medtronic to pay Acutus $17M following EU MDR submission of left-heart access portfolio Earlier this year, Acutus agreed to sell its left-heart access portfolio to […]
Johnson & Johnson completes $16.6B Abiomed acquisition
Johnson & Johnson (NYSE:JNJ) announced today that it completed its $16.6 billion acquisition of Abiomed (Nasdaq:ABMD). Abiomed now becomes part of Johnson & Johnson, operating as a standalone business within its MedTech segment. “We are excited to officially welcome the talented Abiomed team to Johnson & Johnson. Their patient-first philosophy aligns with our credo and our […]
J&J’s Auris alleges former employees brought trade secrets to new company Noah Medical
Johnson & Johnson‘s Auris Health surgical robotics business filed litigation this week alleging misappropriation of trade secrets by Noah Medical. In its complaint filed in U.S. District Court in Northern California, Auris alleges “shameless, systematic and ongoing misappropriation of trade secrets” by Noah. It named former Auris employees Enrique Romo, Diana Cardona Ujueta and Kenneth […]
J&J leads $85M raise for HistoSonics
HistoSonics announced today that it raised $85 million in a financing round led by Johnson & Johnson Innovation. Minneapolis-based HistoSonics develops a novel sonic beam therapy. This uses histotripsy, which mechanically destroys and liquified unwanted tissue and tumors at sub-cellular levels. It develops the non-invasive Edison platform that combines imaging with proprietary sensing technology to […]
Johnson & Johnson extends tender offer for Abiomed acquisition
Johnson & Johnson (NYSE:JNJ) announced today that it extended the expiration date of its offer to acquire Abiomed (Nasdaq:ABMD). Last month, Johnson & Johnson announced its intention to acquire Abiomed for approximately $16.6 billion. Under the agreement, Johnson & Johnson intends to acquire through tender offer all outstanding Abiomed shares. The deal includes an upfront payment […]
Johnson & Johnson elects CEO Joaquin Duato as board chair
Johnson & Johnson (NYSE:JNJ) announced that its board of directors elected CEO Joaquin Duato to take the position of board chair. Duato succeeds Alex Gorsky, who intends to step down from the role following a brief transitional period. The appointment of Duato becomes effective in January 2023. In August 2021, Gorsky announced plans to hand […]
CMR Surgical and J&J are partnering on surgical robotics
CMR Surgical announced today that Johnson & Johnson MedTech’s Ethicon business will work with CMR to sell its Versius surgical robotics systems in select markets. The collaboration involves commercial teams from the two companies working together. They’ll focus on selling to select hospitals in Italy, France, Germany and Brazil. “By entering into this collaboration agreement […]
Why are so many medical device companies making big investments in Ireland?
Ireland’s foreign direct investment agency has some of the biggest names in medtech investing in the country. Within recent years, a number of major medtech companies celebrated anniversaries. Abbott’s was 70 years, Medtronic’s was 40 and Boston Scientific’s was 25. That’s how long those companies have operated in Ireland. Gerard Kilcommins, Medtronic VP of global […]
16 surgical robotics companies you need to know
Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete. […]
Abiomed stock skyrockets on Q3 results ahead of Johnson & Johnson acquisition
Abiomed (Nasdaq:ABMD) shares soared before hours on third-quarter results and the news of its acquisition by Johnson & Johnson (NYSE:JNJ). Johnson & Johnson announced this morning that it agreed to buy Abiomed for $16.6 billion. Shares of ABMD skyrocketed up more than 50% at $378.30 apiece in morning trading today. MassDevice‘s MedTech 100 Index, which includes […]
